Guth has Friedreich’s Ataxia and chose to raise money at Happy Place Nutrition for Friedreich’s Ataxia Research Alliance ...
Some cats wobble, fall over constantly, and generally have no control over their movements. These cats live with the ...
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...
After the FDA rejected its spinocerebellar ataxia treatment, Biohaven missed out on a $150 million payment from Oberland Capital. Now the company is reshuffling its pipeline to stay alive.
The FDA has issued a CRL to Biohaven regarding the NDA for troriluzole for the treatment of adults with spinocerebellar ataxia.
(Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the positive outcome of its ...
NASA says Artemis 1 is about exploration — but insiders know it’s about control. As rival nations close in on lunar resources, the U.S. is moving fast to secure dominance in what could become the most ...
Biohaven (BHVN) downgraded after FDA setback for VYGLXIA. Learn key risks, pipeline shifts, and what investors should watch next. Click here to read more.
The authors test the hypothesis that the contribution of the cerebellum to cognitive tasks is similar to motor tasks, and is related to the processing of prediction errors (here: violation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback